Clinical Trials Directory

Trials / Completed

CompletedNCT05110430

Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans

In Silico Clinical Trial Comparing the Reading Accuracy of Doctors and a Deep Learning Algorithm for Detection of Metastatic Bone Disease on Bone Scintigraphy Scans.

Status
Completed
Phase
Study type
Observational
Enrollment
2,365 (actual)
Sponsor
Maastricht University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Bone scintigraphy scans are two dimensional medical images that are used heavily in nuclear medicine. The scans detect changes in bone metabolism with high sensitivity, yet it lacks the specificity to underlying causes. Therefore, further imaging would be required to confirm the underlying cause. The aim of this study is to investigate whether deep learning can improve clinical decision based on bone scintigraphy scans.

Conditions

Interventions

TypeNameDescription
OTHERDeep learning based detection of metastatic bone disease on bone scintigraphy scans.The aim is to investigate whether deep learning algorithms can detect bone metastasis with high accuracy and specificity.

Timeline

Start date
2021-03-10
Primary completion
2021-12-30
Completion
2021-12-31
First posted
2021-11-08
Last updated
2023-03-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05110430. Inclusion in this directory is not an endorsement.

Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans (NCT05110430) · Clinical Trials Directory